Institutional Ownership Royalty Pharma PLC (RPRX)
This table provides information about the institutional ownership of Royalty Pharma PLC (RPRX). We have compiled data on the 483 institutions that hold shares in the stock, with a total of 283 Million shares, which have been reported (via 13F filing form) to have a value of $9.28 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
41,029,832
shares
|
$1.35 Billion
0.09% of portfolio
|
Q1 2025
Added 3.79%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
36,677,448
shares
|
$1.2 Billion
0.02% of portfolio
|
Q1 2025
Reduced 1.81%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
23,017,561
shares
|
$756 Million
0.01% of portfolio
|
Q2 2024
Added 8.54%
|
|
|
Baillie Gifford & CO
|
May 07, 2025 Q1 2025 |
13,402,284
shares
|
$440 Million
0.38% of portfolio
|
Q1 2025
Reduced 5.18%
|
|
|
Swedbank Ab
Stockholm, V7 |
Jan 23, 2025 Q4 2024 |
12,164,170
shares
|
$399 Million
0.39% of portfolio
|
Q4 2024
New holding
|
|
|
Viking Global Investors LP
|
May 15, 2025 Q1 2025 |
10,563,939
shares
|
$347 Million
1.1% of portfolio
|
Q1 2025
Reduced 13.47%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
9,516,128
shares
|
$312 Million
0.01% of portfolio
|
Q1 2025
Reduced 2.5%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
7,999,468
shares
|
$263 Million
0.02% of portfolio
|
Q1 2025
Added 9.39%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
6,250,000
shares
|
$205 Million
0.38% of portfolio
|
Q1 2025
Reduced 63.17%
|
|
|
Caledonia (Private) Investments Pty LTD
Sydney Nsw, C3 |
May 15, 2025 Q1 2025 |
5,114,567
shares
|
$168 Million
3.99% of portfolio
|
Q1 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
4,025,583
shares
|
$132 Million
0.01% of portfolio
|
Q1 2025
Added 34.83%
|
|
|
Victory Capital Management Inc
|
May 02, 2025 Q1 2025 |
3,623,134
shares
|
$119 Million
0.12% of portfolio
|
Q1 2025
Added 270.38%
|
|
|
Siguler Guff Advisers, LLC
|
Feb 15, 2023 Q4 2022 |
3,391,754
shares
|
$111 Million
64.43% of portfolio
|
Q4 2022
Reduced 49.84%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
3,122,531
shares
|
$103 Million
0.02% of portfolio
|
Q1 2025
Reduced 0.29%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
2,976,257
shares
|
$97.7 Million
0.01% of portfolio
|
Q1 2025
Reduced 10.63%
|
|
|
Patient Capital Management, LLC
Baltimore, MD |
May 14, 2025 Q1 2025 |
2,972,646
shares
|
$97.6 Million
5.29% of portfolio
|
Q1 2025
Added 3.39%
|
|
|
New South Capital Management Inc
Memphis, TN |
Apr 28, 2025 Q1 2025 |
2,907,469
shares
|
$95.5 Million
4.74% of portfolio
|
Q1 2025
Reduced 1.68%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
2,903,900
shares
|
$95.3 Million
0.21% of portfolio
|
Q1 2025
Reduced 20.94%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 19, 2025 Q1 2025 |
2,847,934
shares
|
$93.5 Million
0.02% of portfolio
|
Q1 2025
Added 8.62%
|
|
|
Legal & General Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
2,810,880
shares
|
$92.3 Million
0.02% of portfolio
|
Q1 2025
Added 6.72%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
2,608,090
shares
|
$85.6 Million
0.09% of portfolio
|
Q1 2025
Added 37.0%
|
|
|
Gmt Capital Corp
Atlanta, GA |
May 15, 2025 Q1 2025 |
2,377,500
shares
|
$78.1 Million
4.07% of portfolio
|
Q1 2025
Reduced 27.24%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
2,065,776
shares
|
$67.8 Million
0.01% of portfolio
|
Q1 2025
Reduced 28.72%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
1,960,718
shares
|
$64.4 Million
0.07% of portfolio
|
Q1 2025
Added 23.35%
|
|
|
Homestead Advisers Corp
|
May 06, 2025 Q1 2025 |
1,931,140
shares
|
$63.4 Million
1.55% of portfolio
|
Q4 2024
Added 3.93%
|